Routes of
administration Oral CAS Number 1307245-86-8 ChEMBL CHEMBL3304244 | Legal status Investigational ChemSpider 34248711 Formula C22H23ClF2N4O2S | |
 | ||
LY-2940094 is a potent and selective nociceptin receptor antagonist which is under investigation by Eli Lilly for the treatment of major depressive disorder and alcohol dependence. It has demonstrated proof-of-concept clinical efficacy for depression. As of 2015, it is in phase II clinical trials for both of the aforementioned indications.
References
LY-2940094 Wikipedia(Text) CC BY-SA